Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021.
Ditsch N, Kolberg-Liedtke C, Friedrich M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Müller V, Janni W, Thill M. Ditsch N, et al. Among authors: mundhenke c. Breast Care (Basel). 2021 Jun;16(3):214-227. doi: 10.1159/000516419. Epub 2021 Jun 1. Breast Care (Basel). 2021. PMID: 34248462 Free PMC article. Review. No abstract available.
[Malignant tumors of the uterus].
Mundhenke C, Bauerschlag D, Fischer D, Friedrich M, Maass N. Mundhenke C, et al. Ther Umsch. 2007 Jul;64(7):381-8. doi: 10.1024/0040-5930.64.7.381. Ther Umsch. 2007. PMID: 17948755 Review. German.
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.
Witzel I, Loibl S, von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, Hauschild M, Lantzsch T, Tesch H, Latos K, Just M, Hilfrich J, Barinoff J, Eulenburg CZ, Roller M, Untch M, Müller V. Witzel I, et al. Among authors: mundhenke c. Breast Cancer Res Treat. 2010 Sep;123(2):437-45. doi: 10.1007/s10549-010-1030-9. Epub 2010 Jul 10. Breast Cancer Res Treat. 2010. PMID: 20623180 Clinical Trial.
Epidemiology of vulvar and vaginal cancer in Germany.
Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Dittmer C, et al. Among authors: mundhenke c. Arch Gynecol Obstet. 2011 Jul;284(1):169-74. doi: 10.1007/s00404-011-1850-9. Epub 2011 Feb 22. Arch Gynecol Obstet. 2011. PMID: 21340687 Review.
Adjuvant Consensus: A Breast Cancer Patient Web Tool.
Jonat W, Mundhenke C, Kaufmann M. Jonat W, et al. Among authors: mundhenke c. Breast Care (Basel). 2008;3(2):114-117. doi: 10.1159/000126737. Epub 2008 Apr 22. Breast Care (Basel). 2008. PMID: 21373214 Free PMC article.
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
von Minckwitz G, Schwedler K, Schmidt M, Barinoff J, Mundhenke C, Cufer T, Maartense E, de Jongh FE, Baumann KH, Bischoff J, Harbeck N, Lück HJ, Maass N, Zielinski C, Andersson M, Stein RC, Nekljudova V, Loibl S; GBG 26/BIG 03-05 study group and participating investigators. von Minckwitz G, et al. Among authors: mundhenke c. Eur J Cancer. 2011 Oct;47(15):2273-81. doi: 10.1016/j.ejca.2011.06.021. Epub 2011 Jul 7. Eur J Cancer. 2011. PMID: 21741829 Clinical Trial.
108 results